Linsidomine hydrochloride
Linsidomine hydrochloride (SIN-1 chloride) is considered as a metabolite of moxidomine, with vasodilation, inhibition of platelet aggregation, and antiangina activity. In myocardial ischemia-reperfusion models, Linsidomine hydrochloride to reduce myocardial necrosis and reperfusion induced endothelial dysfunction is associated with the cavernosal mechanism of action involved in nitric oxide release.
Product Specifications
CAS Number
16142-27-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
206.63
Molecular Formula
C6H11ClN4O2
Notes
Research use only, not for human use.
Receptor
Drug Metabolite
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog